224 related articles for article (PubMed ID: 10665776)
41. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
[TBL] [Abstract][Full Text] [Related]
42. Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
Lienenklaus S; Ames RS; Tornetta MA; Sarau HM; Foley JJ; Crass T; Sohns B; Raffetseder U; Grove M; Hölzer A; Klos A; Köhl J; Bautsch W
J Immunol; 1998 Sep; 161(5):2089-93. PubMed ID: 9725198
[TBL] [Abstract][Full Text] [Related]
43. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.
Desquand S; Lefort J; Dumarey C; Vargaftig BB
Br J Pharmacol; 1990 Jun; 100(2):217-22. PubMed ID: 2379029
[TBL] [Abstract][Full Text] [Related]
44. Role of immunoglobulins G1 and G2 in anaphylactic shock in the guinea pig.
Desquand S; Rothhut B; Vargaftig BB
Int Arch Allergy Appl Immunol; 1990; 93(2-3):184-91. PubMed ID: 2099344
[TBL] [Abstract][Full Text] [Related]
45. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
[TBL] [Abstract][Full Text] [Related]
46. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
47. Impaired sensorineural function after allergen-induced mediator release.
Hsiue TR; Leff AR; Garland A; Hershenson MB; Ray DW; Solway J
Am Rev Respir Dis; 1993 Aug; 148(2):447-54. PubMed ID: 7688201
[TBL] [Abstract][Full Text] [Related]
48. Nitric oxide and β(2)-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice.
Shinomiya S; Shibamoto T; Kurata Y; Kuda Y; Zhang W; Tanida M; Toga H
Exp Lung Res; 2013 Apr; 39(3):119-29. PubMed ID: 23442108
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological modulation of the respiratory and haematological changes accompanying active anaphylaxis in the guinea-pig.
Pretolani M; Page CP; Lefort J; Lagente V; Vargaftig BB
Eur J Pharmacol; 1986 Jun; 125(3):403-9. PubMed ID: 3732399
[TBL] [Abstract][Full Text] [Related]
50. Effects of histamine H1-receptor blockade on respiratory and cardiac manifestation of systemic anaphylaxis.
Felix SB; Baumann G; Hashemi T; Niemczyk M; Ochsenfeld G; Ahmad Z; Shirani S; Blömer H
Agents Actions; 1991 Jul; 33(3-4):349-58. PubMed ID: 1683106
[TBL] [Abstract][Full Text] [Related]
51. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
52. Characterization of a C3a receptor in rainbow trout and Xenopus: the first identification of C3a receptors in nonmammalian species.
Boshra H; Wang T; Hove-Madsen L; Hansen J; Li J; Matlapudi A; Secombes CJ; Tort L; Sunyer JO
J Immunol; 2005 Aug; 175(4):2427-37. PubMed ID: 16081814
[TBL] [Abstract][Full Text] [Related]
53. The Complement C3a and C3a Receptor Pathway in Kidney Diseases.
Gao S; Cui Z; Zhao MH
Front Immunol; 2020; 11():1875. PubMed ID: 32973774
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170).
Heuer HO
Eur J Pharmacol; 1991 Jun; 199(2):157-63. PubMed ID: 1954975
[TBL] [Abstract][Full Text] [Related]
55. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
Grossklaus C; Damerau B; Lemgo E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
[TBL] [Abstract][Full Text] [Related]
56. Changes in bronchial anaphylactic reactivity induced in guinea-pigs by long-term treatment with histamine H2-agents.
Andersson P; Bergstrand H
Br J Pharmacol; 1984 May; 82(1):207-16. PubMed ID: 6203589
[TBL] [Abstract][Full Text] [Related]
57. Changes in airway reactivity to exogenous and endogenous acetylcholine and substance P after anaphylactic bronchoconstriction in anaesthetized guinea-pigs.
Nieri P; Daffonchio L; Omini C; Martinotti E; Breschi MC
J Auton Pharmacol; 1992 Dec; 12(6):403-9. PubMed ID: 1282127
[TBL] [Abstract][Full Text] [Related]
58. Airway hyper- or hyporeactivity to inhaled spasmogens 24 h after ovalbumin challenge of sensitized guinea-pigs.
Lewis CA; Broadley KJ
Br J Pharmacol; 1995 Nov; 116(5):2351-8. PubMed ID: 8581268
[TBL] [Abstract][Full Text] [Related]
59. The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen.
Kawamoto S; Yalcindag A; Laouini D; Brodeur S; Bryce P; Lu B; Humbles AA; Oettgen H; Gerard C; Geha RS
J Clin Invest; 2004 Aug; 114(3):399-407. PubMed ID: 15286806
[TBL] [Abstract][Full Text] [Related]
60. The C3a receptor antagonist SB 290157 has agonist activity.
Mathieu MC; Sawyer N; Greig GM; Hamel M; Kargman S; Ducharme Y; Lau CK; Friesen RW; O'Neill GP; Gervais FG; Therien AG
Immunol Lett; 2005 Sep; 100(2):139-45. PubMed ID: 16154494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
